10.02.19
Brittany Jackway, senior manager, sales and business development, Alcami Corporation, was on hand at Contract Pharma 2019 to disuss the company's full service CDMO offerings.
Breaking News
VIDEO: Alcami's Brittany Jackway
Alcami's senior manager for sales and business development talks with Contract Pharma.
Brittany Jackway, senior manager, sales and business development, Alcami Corporation, was on hand at Contract Pharma 2019 to disuss the company's full service CDMO offerings.
Related Breaking News
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Senti Bio Invests in Cell Therapy Manufacturing Facility
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Breaking News | Collaborations & Alliances
Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients
Cryoport will provide tracking and proactive management for the therapies.06.22.21
-
Breaking News | Industry News | Preclinical Outsourcing
Vectura, Incannex Enter Preclinical Services Agreement
Vectura to provide development services for IHL-216A, Incannex’s inhaled drug product for the treatment of traumatic brain injury.06.22.21
-
Breaking News | Clinical Trial Materials | Industry News
CaroGen, BioCentriq Enter Clinical Manufacturing Pact
BioCentriq to provide clinical manufacturing to support Phase 1 clinical trials of CaroGen's lead immunotherapy candidate, CARG-201.06.22.21
-
Breaking News | Packaging & Tracking
Schreiner MediPharm, Plas-Tech Partner on Prefilled Syringe Cap-Lock
Companies combine expertise on Cap-Lock tamper-evident security system for luer-lock syringes.06.22.21
-
Breaking News | Collaborations & Alliances
Iksuda, LegoChem Expand ADC Alliance
Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.06.22.21
-
Collaborations & Alliances | Drug Development
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate
ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.06.22.21
-
Breaking News | Clinical Trials | CRO News
Syneos Expands Decentralized Trial Capabilities
Aims to accelerate decentralized clinical trial delivery through collaboration with site sponsors.06.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Danaher To Acquire Aldevron for $9.6B
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.06.21.21
-
Breaking News | Facilities | Formulation Development | Industry News
Coriolis Pharma Expands ATMP Development Facilities
Construction of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by 4Q21.06.21.21
-
Breaking News | Collaborations & Alliances | Drug Development
Jacobio Earns $20M AbbVie Milestone
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.06.18.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai, BMS Enter Global Anticancer ADC Alliance
BMS to pay as much as $2.45B to co-develop Eisai’s MORAb-20206.18.21
-
Breaking News | Industry News | Laboratory Testing
